Abstract 1224: Discovery of novel BAF inhibitors for the treatment of transcription factor-driven cancers
Centore, Richard C., Soares, Luis M., Vaswani, Rishi G., Ichikawa, Kana, Li, Zhifang, Fan, Hong, Setser, Jeremy, Lahr, David L., Zawadzke, Laura, Chen, Xueying, Barnash, Kimberly D., Muwanguzi, Jordana, Anthony, Neville, Sandoval, Gabriel J., Feldman, Katharine, Adam, Ammar, Huang, David, Schiller, Shawn, Wilson, Kevin, Voigt, Johannes, Hentemann, Martin, Millan, David S., Chan, Ho Man, Bellon, Steven F., Decicco, Carl P., Xu, Lan
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract A064: Establishing the cellular and molecular impacts of the dual BRM/BRG1 inhibitor FHD-286 on pre-clinical models of non-small cell lung cancer (NSCLC)
Wilson, Molly M., Adam, Ammar, Amaral, Victoria, Mikse, Oliver, Elliott, GiNell, Lahr, David L., Gartin, Ashley K., Wan, Jessica, Johannessen, Liv, Ichikawa, Kana, Feldman, Katharine, Piel, Jessica, Sandoval, Gabriel J., Centore, Richard C., Bellon, Steven F., Hentemann, Martin
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article
Abstract LB190: Modulation of SPI1 transcriptional program contributes to the preclinical anti-tumor activity of SMARCA4/SMARCA2 ATPase inhibitors in AML
Sandoval, Gabriel J., Feldman, Katharine, Topal, Sal, Adam, Ammar, Wu, Hsin-Jung, Sappal, Darshan, Soares, Luis M., Lahr, David L., Xu, Lan, Vaswani, Rishi G., Muwanguzi, Jordana, Huang, Liyue, Piel, Jessica, Collins, Mike, Chan, Ho Man, Thomenius, Michael J., Bellon, Steven F., Kruger, Ryan G., Decicco, Carl P., Centore, Richard C., Hentemann, Martin
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article